Method for reducing blood cholesterol using arginine

• US 5,157,022 A
• Filed: 11/22/1989
• Issued: 10/20/1992
• Est. Priority Date: 11/22/1989
• Status: Expired due to Term

• Current Assignee: Adrian Barbul
• Original Assignee: Adrian Barbul
• Inventors: Barbul, Adrian
• Primary Examiner(s): LEE, LESTER
• Application Number:
  US07/440,589
• Time in Patent Office: 1,063 Days
• Field of Search: 514/18, 514/19, 514/356, 514/561, 546/318
• US Class Current: 514/7.4
• CPC Class Codes: A61K 31/195 having an amino group
• CPC Class Codes: A61K 38/04 Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof enzyme inhibitors A61K38/005; gastrins A61K38/2207, somatostatins A61K38/31, melanotropins A61K38/34 ; protease inhibitors A61K38/55
• CPC Class Codes: A61P 3/06 Antihyperlipidemics
• CPC Class Codes: A61P 9/10 for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

A method for reducing the level of cholesterol in the bloodstream of a human being in provided. The method comprises the administration to a human or arginine derivative compound, or a related amino acid or derivative. Daily doses of these compounds have been found to significantly reduce blood cholesterol level.

Claims

1. A method for reducing the level of cholesterol in the bloodstream of a human being comprising administering to said being a pharmaceutically effective amount of a compound selected from the group consisting of arginine nicotinate, and di and tri-peptides containing at least one arginine unit.

2. The method of claim 1, wherein said compound comprises arginine in an amount between about 1 and 30 grams per daily dosage.

3. The method of claim 2, wherein said arginine is an amount between about 3 and 24 grams per daily dosage.

4. The method of claim 1, wherein said compound is arginine nicotinate.

5. The method of claim 1, wherein said compound is selected from the group consisting of di and tri-peptides containing at least one arginine unit.

6. The method of claim 5, wherein said di and tri-peptides are selected consisting of alanyl-arginine, valinyl-arginine, isoleucinyl arginine, leucinyl arginine, arginyl-lysinyl-glutamic acid and arginyl-glysyl-arginine.

7. A method for treating high cholesterol in a living being comprising:

administering to said living being a pharmaceutically effective amount of the compound selected from the group consisting of arginine nicotinate, di and tri-peptides containing at least one arginine unit and an ornithine HCl; and

selectively measuring the level of serum cholesterol in the bloodstream of said living being.

8. The method of claim 7, wherein said compound is administered to said living being on a daily basis containing arginine in an amount between about 10 mg/kg body weight of said living being and 500 mg/kg body weight of said living being.

9. The method of claim 8, wherein said compound is arginine nicotinate, and wherein said arginine nicotinate is administered to said living being on a daily basis containing arginine in an amount between about 10 mg/kg body weight of said living being and 100 mg/kg body weight of said living being.

10. A compound suitable for reducing the level of cholesterol in a living being by the administration thereof of a pharmaceutically effective amount to said living being comprising arginine nicotinate.

11. The compound of claim 10, wherein said daily dosage of said arginine nicotinate contains arginine in an amount between about 10 mg/kg body weight of said living being and 100 mg/kg body weight of said living being.

12. A composition comprising an ester of arginine and nicotinic acid.

14. The method of claim 12, wherein said arginine or arginine derivative compound is selected from the group including arginine salts.

13. A method for reducing the level of cholesterol in the bloodstream of a living being comprising administering to said living being on a daily basis a compound selected from the group consisting of arginine nicotinate, di and tri-peptides containing at least one arginine unit and an ornithine HCl in an amount between about 10 mg/kg body weight of said living being and 500 mg/kg body weight of all living beings.

15. The method of claim 13, wherein said compound is arginine nicotinate.

16. The method of claim 15, wherein said di and tri-peptides are selected from the group consisting of alanyl-arginine, valinyl-arginine, isoleucinyl arginine, leucinyl arginine, arginyl-lysinyl-glutamic acid and arginyl-glysyl-arginine.

17. A method for reducing the level of blood cholesterol in a human being comprising administering to said being a pharmaceutically effective amount of an ornithine HCl.